Evaluating two radiotherapy-plus-chemotherapy strategies in bladder cancer patients undergoing bladder surgery

As part of coverage of the 2018 Genitourinary Cancers Symposium in San Francisco, Cancer Network spoke with John Coen, a radiation oncologist who specialises in the care of patients with bladder and prostate cancer. Dr Coen presented results of the Radiation Therapy Oncology Group (RTOG) 0712 trial, a phase II study exploring two different radiotherapy-plus-chemotherapy combination strategies in patients undergoing bladder surgery for their tumours.
Cancer Network